Kevin Feeley - 01 Mar 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Bridget Brown, Attorney-in-Fact
Issuer symbol: WGS
Transactions as of: 01 Mar 2025
Net transactions value: -$27,128
Form type: 4
Filing time: 04 Mar 2025, 16:36:05 UTC
Previous filing: 31 Jan 2025
Next filing: 11 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WGS	Class A Common Stock	Options Exercise	$0	+717	+21%	$0.000000	4,167	01 Mar 2025	Direct	F1, F2
transaction	WGS	Class A Common Stock	Sale	$27,128	-261	-6.3%	$103.94	3,906	03 Mar 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WGS	Restricted Stock Unit	Options Exercise	$0	-717	-15%	$0.000000	4,034	01 Mar 2025	Class A Common Stock	717		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2	Reflects the acquisition of 500 shares acquired under the Company's Employee Stock Purchase Plan on October 31, 2024.
F3	The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction.
F4	6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.